| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Research and development | $11.5M-56.0% | $26.1M-4.1% | $27.3M+41.9% | $19.2M+9.3% | $17.6M+73.4% | $10.1M |
| General and administrative | $11.5M-55.2% | $25.6M+119.3% | $11.7M+21.9% | $9.6M+46.6% | $6.5M+27.1% | $5.1M |
| Total operating expenses | $23.0M-55.6% | $51.8M+32.9% | $39.0M+35.2% | $28.8M+19.4% | $24.1M+57.8% | $15.3M |
| LOSS FROM OPERATIONS | -$23.0M+55.6% | -$51.8M-32.9% | -$39.0M-35.2% | -$28.8M-19.4% | -$24.1M-57.8% | -$15.3M |
| Warrant issuance expense | -$7.7M | — | -$470K | — | — | — |
| Gain on valuation of warrants | $754K-94.5% | $13.8M+464.3% | -$3.8M | — | — | — |
| Interest income | $435K-64.1% | $1.2M+212.8% | $387K+153.8% | $153K+6577.7% | $2K-79.0% | $11K |
| Total other income (expense), net | $1.2M-83.6% | $7.3M+287.7% | -$3.9M-2637.4% | $153K+1610.2% | $9K-95.5% | $196K |
| LOSS BEFORE INCOME TAXES | -$21.8M+51.0% | -$44.5M-3.9% | -$42.8M-49.4% | -$28.7M-18.8% | -$24.1M | — |
| INCOME TAX PROVISION (BENEFIT) | $66K | — | -$60K+0.0% | -$60K | — | — |
| NET LOSS | -$21.8M+51.1% | -$44.6M-4.2% | -$42.8M-49.5% | -$28.6M-18.6% | -$24.1M-59.8% | -$15.1M |
| NET LOSS PER SHARE - BASIC (In dollars per share) | -$8.35+77.1% | -$36.52-943.4% | -$3.50+13.6% | -$4.05+6.9% | -$4.35-472.4% | -$0.76 |
| NET LOSS PER SHARE - DILUTED (In dollars per share) | -$8.35+80.1% | -$41.89-1096.9% | -$3.50+13.6% | -$4.05+6.9% | -$4.35-136.4% | -$1.84 |
| WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING - BASIC (In shares) | 2.6M+113.7% | 1.2M-90.0% | 12.2M+73.2% | 7.1M+27.1% | 5.6M-72.0% | 19.8M |
| WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING - DILUTED (In shares) | 2.6M+110.7% | 1.2M-89.9% | 12.2M+73.2% | 7.1M+27.1% | 5.6M-72.0% | 19.8M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.